Sangamo Therapeutics Inc (NASDAQ:SGMO)

25.35
Delayed Data
As of 3:59pm ET
 +3.15 / +14.19%
Today’s Change
3.65
Today|||52-Week Range
27.40
+54.57%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Year
Trend

2013

2014

2015

2016
Operating ActivitiesNet Income / Starting Line-26.6M-26.4M-40.7M-71.7M
 
 
 
 
 
Depreciation569.0K549.0K988.0K997.0K
 
 
 
 
 
Total Other Cash Flow7.1M10.5M6.9M15.4M
 
 
 
 
 
Funds From Operations-18.9M-15.3M-32.8M-55.3M
 
 
 
 
 
Funds From/For Other Operating Expenses225.0K-9.7M910.0K10.6M
 
 
 
 
 
Net Cash Flow - Operating Activities-19.2M-5.7M-33.7M-65.9M
 
 
 
 
 
 
InvestingIncrease In Investments-118.9M-227.8M-258.0M-218.6M
 
 
 
 
 
Decrease In Investments51.1M127.8M337.9M237.5M
 
 
 
 
 
Capital Expenditures-432.0K-621.0K-2.4M-732.0K
 
 
 
 
 
Fixed Asset Disposal79.0K0.000.000.00
 
 
Net Cash Flow Investing-68.1M-100.7M77.5M18.1M
 
 
 
 
 
 
FinancingShort Term Borrowings0.000.000.000.00--
Long Term Borrowings0.000.000.000.00--
Long Term Debt Reduction0.000.000.000.00--
Net Proceeds Stock Sale78.1M106.7M6.8M1.1M
 
 
 
 
 
Common Preferred Redeemed0.000.000.000.00--
Common Dividends0.000.000.000.00--
Cash Dividends Paid - Total0.000.000.000.00--
Other Sources - Financing----14.5M0.00
 
 
Other Uses - Financing2.0M4.6M1.5M776.0K
 
 
 
 
 
Net Cash Flow - Financing76.1M102.2M19.7M337.0K
 
 
 
 
 
 
Exchange RateEffect of Exchange Rate on Cash0.000.00------
 
Net Change In Cash-11.2M-4.2M63.5M-47.4M